Recursion Pharmaceuticals
RXRX
#4956
Rank
S$2.56 B
Marketcap
S$4.78
Share price
-3.86%
Change (1 day)
-21.61%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: S$2.56 Billion

As of September 2026 Recursion Pharmaceuticals has a market cap of S$2.56 Billion. This makes Recursion Pharmaceuticals the world's 4956th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.56 B-9.94%
2025S$2.84 B-27.53%
2024S$3.92 B39.62%
2023S$2.81 B43.48%
2022S$1.95 B-49.94%
2021S$3.91 B

End of Day market cap according to different sources

On Sep 26th, 2026 the market cap of Recursion Pharmaceuticals was reported to be:

S$2.55 Billion
by Nasdaq info icon info icon
S$2.56 Billion
by CompaniesMarketCap info icon info icon